2cureX AB (publ) (FRA:2QE)

Market Cap	5.32M -24.2%
Revenue (ttm)	174.00K -49.7%
Net Income	-2.32M
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1592
Previous Close	0.1630
Day's Range	0.1592 - 0.1592
52-Week Range	0.0432 - 0.3210
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About 2cureX AB

2cureX AB (publ) operates as a medical technology company in Europe. ts proprietary IndiTreat test family creates various three-dimensional tumoroids derived from fresh samples of colorectal cancer (CRC) tissue that has been obtained from an individual patient’s metastatic colorectal cancer. 2cureX AB (publ) was incorporated in 2006 and is based in Landskrona, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2QE

Financial Performance

In 2023, 2cureX AB's revenue was 2.95 million, a decrease of -12.53% compared to the previous year's 3.37 million. Losses were -32.52 million, 9.23% more than in 2022.

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 19, 2026

Data Sources Report a data error